Top Page
Beneficient
(NASDAQ:BENF)
Beneficient (BENF) vs. SPDR S&P 500 ETF (SPY)
Beneficient Business Overview & Revenue Model
Beneficient Earnings Call Summary
Beneficient Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | -29.12M | -7.95M | -98.91M | -104.99M | 101.98M | 60.29M |
| Gross Profit | -29.36M | -24.80M | -164.04M | -150.52M | 81.20M | 60.29M |
| EBITDA | -86.60M | -35.40M | -2.64B | -234.09M | -13.81M | -135.05M |
| Net Income | -78.12M | 51.16M | -2.10B | -130.98M | -58.04M | -334.04M |
Balance Sheet | ||||||
| Total Assets | 316.23M | 354.88M | 368.50M | 368.50M | 3.14B | 2.82B |
| Cash, Cash Equivalents and Short-Term Investments | 6.68M | 1.35M | 7.91M | 7.91M | 70.59M | 12.49M |
| Total Debt | 103.96M | 117.90M | 130.25M | 130.25M | 171.59M | 256.34M |
| Total Liabilities | 368.53M | 299.27M | 309.57M | 309.57M | 241.43M | 282.84M |
| Stockholders Equity | -222.89M | -167.00M | -234.35M | -234.35M | 1.44B | 621.50M |
Cash Flow | ||||||
| Free Cash Flow | -44.07M | -38.80M | -59.98M | -97.19M | -57.23M | -54.17M |
| Operating Cash Flow | -43.81M | -37.70M | -58.22M | -95.12M | -54.01M | -51.19M |
| Investing Cash Flow | 59.77M | 28.11M | 44.06M | 63.02M | -5.98M | 70.44M |
| Financing Cash Flow | -15.85M | 2.97M | 12.59M | -34.46M | 43.86M | -5.24M |
Beneficient Technical Analysis
Beneficient Risk Analysis
Beneficient Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
59 Neutral | $6.95M | -4.08 | -25.88% | 1.07% | 66.65% | -1497.99% | |
57 Neutral | $37.85M | 58.91 | 5.87% | ― | -37.08% | ― | |
45 Neutral | $8.42M | -0.06 | -1438.14% | ― | -62.09% | -99.89% | |
44 Neutral | $64.89M | -0.05 | ― | ― | -33.98% | 94.83% | |
41 Neutral | $8.43M | >-0.01 | ― | ― | ― | ― | |
34 Underperform | $17.17M | -0.70 | -109.09% | ― | ― | 60.78% |
Beneficient Corporate Events
On January 21, 2026, Beneficient announced that the U.S. District Court for the Northern District of Texas had approved a previously disclosed settlement agreement resolving all GWG Holdings-related lawsuits in that court against the company, its subsidiaries and current and former directors and officers; this follows a March 10, 2025 binding settlement agreement and a June 2025 approval by the U.S. Bankruptcy Court for the Southern District of Texas. The settlement, which is to be paid within applicable insurance policy limits and involves no admission of fault or liability by Beneficient or any defendant, fully and finally resolves the GWG litigation against the Beneficient parties and enables the company, according to interim CEO James Silk, to refocus on executing its business strategy, although certain GWG-related claims remain outstanding against entities tied to the former CEO, for which Beneficient may have indemnification obligations.
The most recent analyst rating on (BENF) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Beneficient stock, see the BENF Stock Forecast page.
On January 20, 2026, Beneficient announced it had repaid approximately $27.5 million in loans tied to a credit agreement originally entered into on October 19, 2023, with HH-BDH LLC (whose sole member is Hicks Holdings Operating, LLC) and a Texas state bank, fully satisfying all outstanding principal owed to the bank roughly ten months ahead of the loans’ original October 19, 2026 maturity date. While about $1.66 million in interest and fees remains payable to Hicks Holdings and has been deferred, the company emphasized that the early payoff eliminates its obligations to the bank under the credit agreement and will fully discharge its remaining commitments to Hicks Holdings once these outstanding amounts are settled, a move management framed as a significant milestone in strengthening the balance sheet, reducing leverage, and enhancing financial flexibility to pursue its strategic priorities and long-term value creation for shareholders.
The most recent analyst rating on (BENF) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on Beneficient stock, see the BENF Stock Forecast page.
On January 5, 2026, Beneficient funded the closing of a primary capital transaction involving a limited partner interest in an investment fund with a net asset value of about $3 million, issuing 302,273 shares of its newly designated Series B-9 Resettable Convertible Preferred Stock in a private, unregistered offering. The Series B-9 preferred shares, authorized up to 302,273 shares and convertible into a maximum of 565,007 shares of Class A common stock at an initial but periodically reset conversion price, carry no voting rights, rank pari passu with common stock for dividends and liquidation alongside other designated preferred series, and are subject to ownership and exchange caps, as well as optional and mandatory conversion features tied to regulatory filings and resale eligibility. In a related January 8, 2026 announcement, the company detailed that roughly $3 million in stated value of its resettable convertible preferred stock was provided as primary capital to Cork & Vines Fund I, LP, a fund focused on premium experiential and luxury dining investments, marking a second GP Primary Capital transaction with this manager and increasing the collateral backing Beneficient’s ExAlt loan portfolio by about $3 million of alternative asset interests, thereby expanding its GP Primary Commitment Program and reinforcing its positioning as a provider of fundraising-linked primary capital solutions to general partners.
The most recent analyst rating on (BENF) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Beneficient stock, see the BENF Stock Forecast page.
On January 2, 2026, Beneficient received notification from a Nasdaq Hearings Panel that it had regained compliance with Nasdaq’s minimum bid price rule and the continued listing requirements for warrants, and the company disclosed on January 5, 2026, that it is now in full compliance with all Nasdaq Capital Market listing standards. The restored compliance removes an overhang related to its Nasdaq listing status and helps stabilize Beneficient’s market position as it continues to pursue its business model in alternative asset liquidity and services for underserved investors.
The most recent analyst rating on (BENF) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Beneficient stock, see the BENF Stock Forecast page.
Beneficient announced that its Board of Directors appointed Peter T. Cangany Jr. as Chairman of the Board, effective December 15, 2025. Mr. Cangany brings decades of leadership in financial services, corporate governance, and financial reporting, having previously served as a director of Beneficient since 2019 and held senior leadership positions at Ernst & Young LLP for nearly 40 years. His appointment is expected to bolster Beneficient’s strategic approach and long-term shareholder value creation.
On December 1, 2025, Beneficient‘s stockholders approved a reverse stock split of its Class A and Class B common stock at a ratio of 1-for-8, which was subsequently approved by the Board of Directors to take effect on December 15, 2025. This move is intended to help Beneficient regain compliance with Nasdaq’s minimum bid price requirement. The reverse stock split will reduce the number of shares issued and outstanding and proportionally decrease the number of authorized shares, while increasing the exercise or conversion price per share. Beneficient’s Class A Common Stock will continue trading under the symbol ‘BENF’ on a split-adjusted basis starting December 15, 2025.
On December 10, 2025, Beneficient announced the passing of Thomas O. Hicks, Chairman of its Board of Directors, who died on December 6, 2025, at the age of 79. Hicks was a pioneering figure in private equity and had a significant impact on the company and the city of Dallas. Beneficient’s Board and management are committed to honoring his legacy by continuing to execute the company’s mission with the vision and courage he exemplified.
On December 1, 2025, Beneficient held a Special Meeting of Stockholders where approximately 92.8% of the company’s total voting power was represented. During this meeting, stockholders approved two key proposals: a reverse stock split of the company’s common stock at a ratio between 1-for-5 and 1-for-100, and an adjournment of the meeting if necessary to secure further proxy votes. These approvals are significant for Beneficient’s operational strategies and shareholder engagement.
On November 5, 2025, Beneficient announced the indictment of its former Chairman and CEO, Brad Heppner, by the United States Attorney for the Southern District of New York. Beneficient had previously parted ways with Heppner after discovering credible evidence of his fraudulent activities. The company is pursuing potential claims against him and is cooperating with the government’s investigation. These developments are seen as a step towards strengthening Beneficient’s foundation for growth and transparency, while maintaining its focus on delivering innovative liquidity and trust solutions for alternative asset holders.